Edition:
United States

Soligenix Inc (SNGX.OQ)

SNGX.OQ on NASDAQ Stock Exchange Capital Market

1.04USD
12 Nov 2018
Change (% chg)

$-0.06 (-5.45%)
Prev Close
$1.10
Open
$1.10
Day's High
$1.12
Day's Low
$1.03
Volume
11,320
Avg. Vol
39,419
52-wk High
$3.70
52-wk Low
$0.91

Chart for

About

Soligenix, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $19.45
Shares Outstanding(Mil.): 17.68
Dividend: --
Yield (%): --

Financials

  SNGX.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -0.83 -- --
ROI: -127.83 -0.53 12.77
ROE: -127.83 -3.22 14.47

Earnings vs. Estimates